Showing 48,041 - 48,060 results of 227,376 for search '(( a ((((teer decrease) OR (a decrease))) OR (linear decrease)) ) OR ( i large decrease ))', query time: 2.14s Refine Results
  1. 48041

    Population impact of lung cancer screening in the United States: Projections from a microsimulation model by Steven D. Criss (3821332)

    Published 2018
    “…</p><p>Methods/Findings</p><p>Utilizing a well-validated microsimulation model, we estimated the benefits and harms of an annual low-dose computed tomography screening scenario with a realistic screening adherence rate versus a no-screening scenario for the US population from 2016–2030. …”
  2. 48042

    Data_Sheet_1_Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson’s Disease.PDF by Kevin Novak (2687695)

    Published 2022
    “…<p>Background: Quantitative electroencephalography (qEEG) has been suggested as a biomarker for cognitive decline in Parkinson’s disease (PD).…”
  3. 48043

    Table 2_Understanding adaptations in a community-vetted COVID-19 testing program.pdf by Breanna J. Reyes (21007010)

    Published 2025
    “…Unplanned adaptations were defined as a change made without shared discussion and agreement among at least 2 research team members. …”
  4. 48044

    A sequential radiation-sorafenib regimen is most efficacious against HCC <i>in vivo</i>. by Aaron T. Wild (418957)

    Published 2013
    “…<p>A HepG2 hind-flank xenograft model was utilized to measure the efficacy of (A) 5 different treatment arms: control (sham injection of vehicle control on days 1–5), sorafenib alone (SOR; injection of 6 mg/mL sorafenib on days 1–5), radiation alone (RT; irradiation at a dose of 3 Gy on days 1–3), concurrent radiation-sorafenib (CONC; sorafenib injection on days 1–5 and irradiation at a dose of 3 Gy on days 2–4), and sequential radiation-sorafenib (SEQ; irradiation at a dose of 3 Gy on days 1–3 and sorafenib injection on days 4–8). …”
  5. 48045

    A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma by Giselle L. Saulnier Sholler (745739)

    Published 2015
    “…</p><p>Trial Registration</p><p>Clinicaltrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT01059071" target="_blank">NCT#01059071</a></p></div>…”
  6. 48046

    Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease by Ludovic Belle (293091)

    Published 2016
    “…The Platelet-derived Grotwth Factor (PDGF) and the Transforming Growth Factor-β (TGF-β) play a significant role in the fibrosing process occurring in scl-cGVHD. …”
  7. 48047

    Table1_Efficacy of acupuncture for hypertension in the elderly: a systematic review and meta-analysis.docx by Tianyi Wang (220185)

    Published 2023
    “…Background<p>Hypertension has now developed into a major public health problem worldwide. Under the existing antihypertensive drug treatment paradigm, problems such as decreasing drug resistance and increasing drug side effects can occur for elderly patients. …”
  8. 48048

    Genetic variations at 8q24 and gastric cancer susceptibility: A meta-analysis study by Pengke Zhi (4678540)

    Published 2017
    “…The pooled results of these studies indicated that there was no significant association between both genetic variants and GC susceptibility using an allele, dominant, recessive and homozygote genetic models. When using a heterozygote genetic model, a significant increase was found in the association of GC risk for rs6983267 SNP (OR = 1.07, 95% CI = 1.01–1.12, <i>P</i> = 0.015), whereas for rs1447295 SNP a significant decreased risk was detected (OR = 0.82, 95% CI = 0.69–0.98, <i>P</i> = 0.030). …”
  9. 48049

    Table 1_Understanding adaptations in a community-vetted COVID-19 testing program.pdf by Breanna J. Reyes (21007010)

    Published 2025
    “…Unplanned adaptations were defined as a change made without shared discussion and agreement among at least 2 research team members. …”
  10. 48050

    How Diverse Are Diversity Assessment Methods? A Comparative Analysis and Benchmarking of Molecular Descriptor Space by Alexios Koutsoukas (1773175)

    Published 2014
    “…Chemical diversity is a widely applied approach to select structurally diverse subsets of molecules, often with the objective of maximizing the number of hits in biological screening. …”
  11. 48051

    OroA inhibition of LPS-induced NF-κB activation in lung tissue of the rats. by Tzu-Ling Tseng (288836)

    Published 2013
    “…<p>LPS treatment (10 mg/kg, iv) significantly decreased cytosolic NF-κBp65 expression in lung tissue (Lane 2 in Fig. 6A) comparing to that by Sal (Saline) followed by Solv (Solvent) treatment (Lane 1 in Fig. 6A). …”
  12. 48052

    A missense variant in <i>FTCD</i> is associated with arsenic metabolism and toxicity phenotypes in Bangladesh by Brandon L. Pierce (181635)

    Published 2019
    “…Among the 19,992 coding variants analyzed exome-wide, the minor allele (A) of rs61735836 (p.Val101Met) in exon 3 of <i>FTCD</i> (formiminotransferase cyclodeaminase) was associated with increased urinary iAs% (P = 8x10<sup>-13</sup>), increased MMA% (P = 2x10<sup>-16</sup>) and decreased DMA% (P = 6x10<sup>-23</sup>). …”
  13. 48053
  14. 48054

    Table_S2_Substance Use in Mild-COVID-19 Patients: A Retrospective Study.XLSX by Flavia Ismael (6426614)

    Published 2021
    “…<p>Background: There is a need for prospective studies investigating substance use variations in mild COVID-19 patients. …”
  15. 48055

    How Diverse Are Diversity Assessment Methods? A Comparative Analysis and Benchmarking of Molecular Descriptor Space by Alexios Koutsoukas (1773175)

    Published 2014
    “…Chemical diversity is a widely applied approach to select structurally diverse subsets of molecules, often with the objective of maximizing the number of hits in biological screening. …”
  16. 48056

    Table_S3_Substance Use in Mild-COVID-19 Patients: A Retrospective Study.XLSX by Flavia Ismael (6426614)

    Published 2021
    “…<p>Background: There is a need for prospective studies investigating substance use variations in mild COVID-19 patients. …”
  17. 48057

    Table_S3_Substance Use in Mild-COVID-19 Patients: A Retrospective Study.XLSX by Flavia Ismael (6426614)

    Published 2021
    “…<p>Background: There is a need for prospective studies investigating substance use variations in mild COVID-19 patients. …”
  18. 48058

    Table_S1_Substance Use in Mild-COVID-19 Patients: A Retrospective Study.XLSX by Flavia Ismael (6426614)

    Published 2021
    “…<p>Background: There is a need for prospective studies investigating substance use variations in mild COVID-19 patients. …”
  19. 48059

    Table_S2_Substance Use in Mild-COVID-19 Patients: A Retrospective Study.XLSX by Flavia Ismael (6426614)

    Published 2021
    “…<p>Background: There is a need for prospective studies investigating substance use variations in mild COVID-19 patients. …”
  20. 48060

    Polyamine signaling through the NspS-MbaA circuit specifically controls biofilm gene expression. by Andrew A. Bridges (1587328)

    Published 2022
    “…<i>cholerae</i> (lanes 1–3) or the untreated Δ<i>mbaA</i> strain (lanes 4–5). Red and blue represent increased and decreased gene expression levels, respectively. …”